Prospective, Randomized Trial Comparing En Bloc with Piecemeal Resection of Neoplasia in Barrett’s Esophagus

  • Clinical Trial Information

    Trial Contact: Garcia de Djuro, Ginette

    Trial Phone: 321.841.6649

  • IRB No: 21.070.05

    Protocol Abbrev: BEEPER

    Principal Investigator: Ji Young Bang, MD

    Age Group: Adult

    Treatment: Endoscopic mucosal resection versus Endoscopic submucosal dissection

    Therapies Involved: Surgery ID: NCT03427346

  • Objective

    Rate of complete and curative eradication, free of recurrence of neoplastic Barrett's Esophagus. Endoscopical diagnostic and negative histologies for any kind of neoplasia, measured in follow up control EGD 3 months after end of treatment

  • Key Eligibility

    *patients to be treated for Barrett's esophagus by mucosal resection and following ablative therapy
    *Barrett's mucosal extension up to 10 cm maximum.
    *patient's ability for compliance to therapy
    *signed Informed Consent
    *ages 18-99 years of age